KOD
Price
$3.69
Change
-$0.09 (-2.38%)
Updated
Jun 27 closing price
Capitalization
194.7M
50 days until earnings call
SONN
Price
$1.12
Change
-$0.03 (-2.61%)
Updated
Jun 27 closing price
Capitalization
3.55M
Interact to see
Advertisement

KOD vs SONN

Header iconKOD vs SONN Comparison
Open Charts KOD vs SONNBanner chart's image
Kodiak Sciences
Price$3.69
Change-$0.09 (-2.38%)
Volume$275.49K
Capitalization194.7M
Sonnet BioTherapeutics Holdings
Price$1.12
Change-$0.03 (-2.61%)
Volume$31.95K
Capitalization3.55M
KOD vs SONN Comparison Chart in %
Loading...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KOD vs. SONN commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a Buy and SONN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (KOD: $3.69 vs. SONN: $1.12)
Brand notoriety: KOD and SONN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 73% vs. SONN: 74%
Market capitalization -- KOD: $194.7M vs. SONN: $3.55M
KOD [@Biotechnology] is valued at $194.7M. SONN’s [@Biotechnology] market capitalization is $3.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 1 FA rating(s) are green whileSONN’s FA Score has 0 green FA rating(s).

  • KOD’s FA Score: 1 green, 4 red.
  • SONN’s FA Score: 0 green, 5 red.
According to our system of comparison, KOD is a better buy in the long-term than SONN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 3 TA indicator(s) are bullish while SONN’s TA Score has 4 bullish TA indicator(s).

  • KOD’s TA Score: 3 bullish, 5 bearish.
  • SONN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SONN is a better buy in the short-term than KOD.

Price Growth

KOD (@Biotechnology) experienced а +1.93% price change this week, while SONN (@Biotechnology) price change was -5.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

KOD is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KOD($195M) has a higher market cap than SONN($3.55M). SONN YTD gains are higher at: -23.288 vs. KOD (-62.915). SONN has higher annual earnings (EBITDA): -13.69M vs. KOD (-162.44M). KOD has more cash in the bank: 139M vs. SONN (2.06M). SONN has less debt than KOD: SONN (90.4K) vs KOD (67.6M). SONN has higher revenues than KOD: SONN (1M) vs KOD (0).
KODSONNKOD / SONN
Capitalization195M3.55M5,499%
EBITDA-162.44M-13.69M1,186%
Gain YTD-62.915-23.288270%
P/E RatioN/A0.29-
Revenue01M-
Total Cash139M2.06M6,751%
Total Debt67.6M90.4K74,779%
FUNDAMENTALS RATINGS
KOD vs SONN: Fundamental Ratings
KOD
SONN
OUTLOOK RATING
1..100
7131
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
5187
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KOD's Valuation (27) in the Biotechnology industry is in the same range as SONN (51) in the null industry. This means that KOD’s stock grew similarly to SONN’s over the last 12 months.

KOD's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SONN (100) in the null industry. This means that KOD’s stock grew similarly to SONN’s over the last 12 months.

KOD's SMR Rating (98) in the Biotechnology industry is in the same range as SONN (100) in the null industry. This means that KOD’s stock grew similarly to SONN’s over the last 12 months.

KOD's Price Growth Rating (51) in the Biotechnology industry is somewhat better than the same rating for SONN (87) in the null industry. This means that KOD’s stock grew somewhat faster than SONN’s over the last 12 months.

SONN's P/E Growth Rating (97) in the null industry is in the same range as KOD (100) in the Biotechnology industry. This means that SONN’s stock grew similarly to KOD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KODSONN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENR20.240.33
+1.66%
Energizer Holdings
PFGC87.471.24
+1.44%
Performance Food Group Company
CCBG39.110.30
+0.77%
Capital City Bank Group
IMPP3.100.02
+0.65%
Imperial Petroleum
IMTE0.97-0.02
-2.14%
Integrated Media Technology Limited

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
-2.38%
XNCR - KOD
54%
Loosely correlated
-3.10%
BEAM - KOD
48%
Loosely correlated
-1.98%
NRIX - KOD
48%
Loosely correlated
+0.17%
COGT - KOD
48%
Loosely correlated
-3.14%
IDYA - KOD
46%
Loosely correlated
-4.13%
More

SONN and

Correlation & Price change

A.I.dvisor tells us that SONN and SNBIF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SONN and SNBIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
-2.61%
SNBIF - SONN
28%
Poorly correlated
N/A
KOD - SONN
26%
Poorly correlated
-2.38%
MCRB - SONN
25%
Poorly correlated
-4.31%
XNCR - SONN
25%
Poorly correlated
-3.10%
TPST - SONN
25%
Poorly correlated
-2.68%
More